Search

Your search keyword '"Minelli, Silvia"' showing total 24 results
Start Over Author "Minelli, Silvia" Publication Year Range Last 10 years
24 results on '"Minelli, Silvia"'

1. Brain abscess caused by Actinomyces turicensis in a non-immunocompromised adult patient: a case report and systematic review of the literature

Author

Imeneo, Alessandra, primary, Rindi, Lorenzo Vittorio, additional, Di Lorenzo, Andrea, additional, Cavasio, Rosario Alessandro, additional, Vitale, Pietro, additional, Spalliera, Ilaria, additional, Dauri, Mario, additional, Biasucci, Daniele Guerino, additional, Giuliano, Ilaria, additional, D’Agostini, Cartesio, additional, Minelli, Silvia, additional, Bossa, Maria Cristina, additional, Altieri, Anna, additional, Andreoni, Massimo, additional, Malagnino, Vincenzo, additional, Iannetta, Marco, additional, and Sarmati, Loredana, additional

Published
2024
Full Text
View/download PDF

3. Closing the Gap in Proteomic Identification of Histoplasma capsulatum: A Case Report and Review of Literature

Author

Cosio, Terenzio, primary, Gaziano, Roberta, additional, Fontana, Carla, additional, Pistoia, Enrico Salvatore, additional, Petruccelli, Rosalba, additional, Favaro, Marco, additional, Pica, Francesca, additional, Minelli, Silvia, additional, Bossa, Maria Cristina, additional, Altieri, Anna, additional, Ombres, Domenico, additional, Zarabian, Nikkia, additional, and D’Agostini, Cartesio, additional

Published
2023
Full Text
View/download PDF

4. Laboratory Automation in Microbiology: Impact on Turnaround Time of Microbiological Samples in COVID Time

Author

Fontana, Carla, primary, Favaro, Marco, additional, Pelliccioni, Marco, additional, Minelli, Silvia, additional, Bossa, Maria Cristina, additional, Altieri, Anna, additional, D’Orazi, Carlo, additional, Paliotta, Federico, additional, Cicchetti, Oriana, additional, Minieri, Marilena, additional, Prezioso, Carla, additional, Limongi, Dolores, additional, and D’agostini, Cartesio, additional

Published
2023
Full Text
View/download PDF

8. Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae subsp. pneumoniae Isolates in a Tertiary Italian Hospital: Identification of a New Mutation of the Carbapenemase Type 3 (KPC-3) Gene Conferring Ceftazidime/Avibactam Resistance

Author

Fontana, Carla, primary, Favaro, Marco, additional, Campogiani, Laura, additional, Malagnino, Vincenzo, additional, Minelli, Silvia, additional, Bossa, Maria Cristina, additional, Altieri, Anna, additional, Andreoni, Massimo, additional, and Sarmati, Loredana, additional

Published
2021
Full Text
View/download PDF

9. Changes in renal function and occurrence of contrast-induced nephropathy after percutaneous coronary interventions in patients with atrial fibrillation treated with non-vitamin K oral anticoagulants or warfarin

Author

Montone, Rocco A., primary, Niccoli, Giampaolo, additional, Tufaro, Vincenzo, additional, Minelli, Silvia, additional, Russo, Michele, additional, Vergni, Federico, additional, Sommariva, Luigi, additional, Pelliccia, Francesco, additional, Bedogni, Francesco, additional, and Crea, Filippo, additional

Published
2019
Full Text
View/download PDF

10. An in-depth analysis of nosocomial bloodstream infections due to Gram-negative bacilli: clinical features, microbiological characteristics and predictors of mortality in a 1 year, prospective study in a large tertiary care Italian hospital

Author

Delle Rose, Diego, primary, Pezzotti, Patrizio, additional, Fontana, Carla, additional, Altieri, Anna, additional, Minelli, Silvia, additional, Mariotti, Benedetta, additional, Cerretti, Raffaella, additional, Leoni, Davide, additional, Andreoni, Massimo, additional, and Sarmati, Loredana, additional

Published
2018
Full Text
View/download PDF

13. Microvascular obstruction is an independent predictor of major adverse cardiovascular events in latecomers after ST-elevation myocardial infarction

Author

Montone, Rocco Antonio, Niccoli, Giampaolo, Minelli, Silvia, Crea, Filippo, Montone RA, Niccoli G (ORCID:0000-0002-3187-6262), Crea F (ORCID:0000-0001-9404-8846), Montone, Rocco Antonio, Niccoli, Giampaolo, Minelli, Silvia, Crea, Filippo, Montone RA, Niccoli G (ORCID:0000-0002-3187-6262), and Crea F (ORCID:0000-0001-9404-8846)

Abstract

Clinical outcome and correlates of coronary microvascular obstruction in latecomers after acute myocardial infarction. [Int J Cardiol. 2017] Is microvascular obstruction independent predictor of the major adverse cardiovascular events in latecomers after ST-elevation myocardial infarction? [Int J Cardiol. 2017]

Published
2017

14. Temporal trends in adverse events after everolimus-eluting bioresorbable vascular scaffold versus everolimus-eluting metallic stent implantation: A meta-analysis of randomized controlled trials

Author

Montone, Rocco Antonio, Niccoli, Giampaolo, De Marco, Federico, Minelli, Silvia, D'Ascenzo, Fabrizio, Testa, Luca, Bedogni, Francesco, Crea, Filippo, Montone, Rocco A., Niccoli, Giampaolo (ORCID:0000-0002-3187-6262), Crea, Filippo (ORCID:0000-0001-9404-8846), Montone, Rocco Antonio, Niccoli, Giampaolo, De Marco, Federico, Minelli, Silvia, D'Ascenzo, Fabrizio, Testa, Luca, Bedogni, Francesco, Crea, Filippo, Montone, Rocco A., Niccoli, Giampaolo (ORCID:0000-0002-3187-6262), and Crea, Filippo (ORCID:0000-0001-9404-8846)

Abstract

Background: Bioresorbable coronary stents have been introduced into clinical practice to improve the outcomes of patients treated with percutaneous coronary intervention. The everolimus-eluting bioresorbable vascular scaffold (BVS) is the most studied of these stent platforms; however, recent trials comparing BVS with everolimus-eluting metallic stents (EES) raised concerns about BVS safety. We aimed to assess the efficacy and safety of BVS versus EES in patients undergoing percutaneous coronary intervention. Methods: We searched Medline, Embase, the Cochrane Central Register of Controlled Trials, scientific sessions abstracts, and relevant Web sites for randomized trials with a follow-up of ≥2 years investigating percutaneous coronary interventions with BVS versus EES. The primary outcomes of our analysis were definite/probable stent thrombosis (ST) and target lesion failure (TLF; device-oriented composite end point of cardiac death, target vessel myocardial infarction, or ischemia-driven target lesion revascularization [TLR]). Secondary outcomes were target vessel myocardial infarction, TLR, and cardiac death. We calculated the risk estimates for main outcomes according to a fixed-effect model. Results: We included 7 trials comprising data for 5583 patients randomized to receive either a BVS (n=3261) or an EES (n=2322). Median follow-up was 24 months (range, 24-36 months). Patients treated with BVS had a higher risk of definite/probable ST compared with patients treated with EES (odds ratio, 3.33; 95% confidence interval, 1.97-5.62; P<0.00001). In particular, patients with BVS had a higher risk of subacute, late, and very late ST, whereas the risk of acute ST was similar. Patients treated with BVS compared with EES had a higher risk at 2 years of TLF (odds ratio, 1.47; 95% confidence interval, 1.14-1.90; P=0.003), driven mainly by an increased risk of target vessel myocardial infarction (odds ratio, 1.73; 95% confidence interval, 1.31-2.28; P=0.0001; I2=0%) and

Published
2017

15. Clinical outcome and correlates of coronary microvascular obstruction in latecomers after acute myocardial infarction

Author

Montone, Rocco Antonio, Niccoli, Giampaolo, Minelli, Silvia, Fracassi, Francesco, Vetrugno, Vincenzo, Aurigemma, Cristina, Burzotta, Francesco, Porto, Italo, Trani, Carlo, Crea, Filippo, Niccoli, Giampaolo (ORCID:0000-0002-3187-6262), Burzotta, Francesco (ORCID:0000-0002-6569-9401), Porto, Italo (ORCID:0000-0002-9854-5046), Trani, Carlo (ORCID:0000-0001-9777-013X), Crea, Filippo (ORCID:0000-0001-9404-8846), Montone, Rocco Antonio, Niccoli, Giampaolo, Minelli, Silvia, Fracassi, Francesco, Vetrugno, Vincenzo, Aurigemma, Cristina, Burzotta, Francesco, Porto, Italo, Trani, Carlo, Crea, Filippo, Niccoli, Giampaolo (ORCID:0000-0002-3187-6262), Burzotta, Francesco (ORCID:0000-0002-6569-9401), Porto, Italo (ORCID:0000-0002-9854-5046), Trani, Carlo (ORCID:0000-0001-9777-013X), and Crea, Filippo (ORCID:0000-0001-9404-8846)

Abstract

Aims Microvascular obstruction (MVO) is associated with a worse prognosis in patients with ST-elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention (PCI). However, data about incidence, clinical outcome and correlates of MVO in latecomers after STEMI are still lacking. Methods We prospectively enrolled consecutive patients that were latecomers after STEMI (symptoms onset > 12 h) undergoing PCI. We performed an angiographic analysis to assess the occurrence of MVO [defined as TIMI flow grade ≤ 2 or 3 with a myocardial blush grade < 2]. Moreover, we performed a clinical and echocardiographic follow-up to assess the occurrence of major adverse cardiovascular events (MACE), defined as the composite of cardiac death, myocardial infarction and rehospitalization for heart failure, and to evaluate left ventricle remodelling. Results Seventy-eight patients were enrolled [mean age 67.58 ± 11.72 years, 57 (73%) male; mean time of symptom onset 23.14 ± 16.06 h] with a mean follow-up time of 29.7 ± 14.1 months. MVO occurred in 39 (50%) patients. Patients with MVO had a higher rate of MACE [18 (46%) vs. 3 (8%), p < 0.001] and LV remodelling [25 (64%) vs. 6 (15%), p < 0.001] compared with patients without MVO. By multivariable Cox regression MVO and left anterior descending artery were independent predictors of MACE. Conclusions Latecomers after STEMI have a high risk to develop MVO that is related to an adverse prognosis. Appropriate management and follow-up strategies should be implemented in such high-risk patients group.

Published
2017

19. An in-depth analysis of nosocomial bloodstream infections due to Gram-negative bacilli: clinical features, microbiological characteristics and predictors of mortality in a 1 year, prospective study in a large tertiary care Italian hospital.

Author

Delle Rose, Diego, Pezzotti, Patrizio, Fontana, Carla, Altieri, Anna, Minelli, Silvia, Mariotti, Benedetta, Cerretti, Raffaella, Leoni, Davide, Andreoni, Massimo, and Sarmati, Loredana

Abstract

Background: Bloodstream infections (BSI) due to Gram negative bacilli (GNB) represent a major concern among nosocomial infections, since they are noticeably associated with a high mortality rates, increase of healthcare costs and prolongation of hospital stay. Methods: Over a 12-month period (2014-2015) all the adult patients admitted to a university-based Italian hospital were monitored for development of BSIs due to GNB. Multiple logistics regression models were performed to assess the impact of patients' risk factors on the in-hospital and 14-day mortality. Results: During the study period 208 patients were diagnosed with at least a BSI due to a Gram negative species for an incidence rate of 12.8 cases/1,000 admissions (95%CI: 11.2-14.7). Multivariate analyses showed that multiple organ dysfunctions along with immune deficit and inadequate therapy in the first 48hrs were associated with a higher risk of death. Conclusions: A thorough evaluation of both immune status and organ dysfunction at the onset of septic events, along with adequate antimicrobial therapy appear to be the most reliable factors in predicting the outcome in these infections. SOFA score can be efficaciously substituted to the single organ dysfunctions analysis in predicting mortality after these events. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

22. Corrigendum to “Permanent polymer of drug eluting stents increases eosinophil cationic protein levels following percutaneous coronary intervention independently of C-reactive protein” [Atherosclerosis 237 (2014) 816–820]

Author

Niccoli, Giampaolo, primary, Calvieri, Camilla, additional, Minelli, Silvia, additional, Copponi, Giorgia, additional, Montone, Rocco A., additional, Imaeva, Asiya, additional, Roberto, Marco, additional, Cosentino, Nicola, additional, and Crea, Filippo, additional

Published
2015
Full Text
View/download PDF

24. Changes in renal function and occurrence of contrast-induced nephropathy after percutaneous coronary interventions in patients with atrial fibrillation treated with non-vitamin K oral anticoagulants or warfarin.

Author

Montone RA, Niccoli G, Tufaro V, Minelli S, Russo M, Vergni F, Sommariva L, Pelliccia F, Bedogni F, and Crea F

Abstract

Introduction: Patients with atrial fibrillation (AF) receiving non-vitamin K oral anticoagulants (NOAC) have a slower decline in renal function than those taking warfarin. Moreover, a warfarin-related nephropathy has been described., Aim: We assessed variation of estimated glomerular filtration rate (eGFR) and occurrence of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI) in patients with AF taking warfarin compared with NOAC., Material and Methods: We retrospectively enrolled consecutive patients taking oral anticoagulation for AF undergoing PCI. The primary endpoint was variation in eGFR and serum creatinine levels within 48-72 h after PCI. The secondary endpoint was occurrence of CIN, defined as a ≥ 25% relative increase, or a ≥ 0.5 mg/dl absolute increase, in serum creatinine levels within 48-72 h., Results: We enrolled 420 patients (mean age: 75.0 ±5.5 years, 272 (64.7%) male), 124 (29.5%) treated with NOAC and 296 (70.5%) with warfarin. NOAC patients showed a reduced decline in renal function (eGFR change: -2.8 ±7.9 ml/min/1.73 m 2 vs. -4.5 ±6.5 ml/min/1.73 m 2 , respectively, p = 0.02) and a smaller increase in serum creatinine levels (0.026 ±0.112 vs. 0.055 ±0.132, p = 0.032) after PCI compared with warfarin. In the multivariate linear regression model independent predictors of eGFR changes were diabetes, baseline eGFR ≤ 60 ml/min/1.73 m 2 and warfarin use. Occurrence of CIN did not differ between NOAC and warfarin patients (13 (10.5%) vs. 46 (15.5%), p = 0.22)., Conclusions: Patients with AF taking NOAC have a reduced decline in renal function after PCI compared with warfarin. The NOAC may be a reasonable option for patients with a high risk of developing CIN., Competing Interests: The authors declare no conflict of interest.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results